Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jeffrey Zheutlin (NPI 1255371647)

Field	Value
Entity Type	Individual
Organization	Jeffrey Zheutlin
Address	2505 E Paris Ave Se
City	Grand Rapids
State	MI
ZIP	49546
Taxonomy	Ophthalmology Physician
NPI Enumerated	June 7, 2006

Payer Source	Total Paid
Medicare	$1.5M
Medicaid	$0

Key Findings

This provider's billing is effectively single‑payer: reported lifetime Medicare revenue is $1.5M and there is no Medicaid billing on file (none below). The absence of Medicaid billing means analyses of payer mix and Medicaid network participation are limited to noting that Medicare dominates this provider's publicly reported volume and revenue.

Revenue is highly concentrated in a small number of drug-injection codes: the precomputed top 3 Medicare codes by revenue account for 86.1% of the provider's total Medicare revenue. Those top codes are J0178 ($735.5K; 47.5% of Medicare revenue), J2778 ($466.2K; 30.1%), and J2777 ($132.2K; 8.5%), indicating most revenue is captured by a few high-volume injectable therapies.

The code mix and descriptions indicate a retina-focused ophthalmology practice that performs frequent intravitreal injections and retinal diagnostic imaging. High-revenue injectable codes J0178 (aflibercept), J2778 (ranibizumab), and J2777 (faricimab) together with procedural code 67028 (injection into the vitreous chamber; $101K, 6.5%) and imaging code 92134 (computerized retinal imaging; $50.7K, 3.3%) point to a service line organized around anti‑VEGF/anti‑angiogenic treatment and associated retinal follow-up.

Competitive standing varies by service: J2778 ranks at the 88th percentile nationally (rank #140 of 1208), indicating above‑typical national volume for ranibizumab injections, while J0178 ranks at the 62th percentile (rank #1212 of 3204), a typical volume level. J2777 is at the 22th percentile (rank #1591 of 2039), showing relatively low national volume for faricimab, and 92134 is at the 95th percentile (rank #1275 of 26868) and is explicitly labeled as notably above typical national volume—together these ranks suggest the provider is a strong regional performer for certain retinal imaging and injection services but not a dominant national leader across all anti‑VEGF agents.

Routine office evaluation-and-management codes show consistent ambulatory follow-up activity: 99214 appears 375 times for $33K (2.1% of Medicare revenue) and 99213 appears 258 times for $16K (1.0% of Medicare revenue), with both codes at the 84th percentile nationally. This pattern supports a workflow of recurring patient follow-ups and management visits that accompany ongoing intravitreal therapy.

Smaller-volume codes provide nuance about therapeutic choices: J9035 (bevacizumab) accounts for 121 claims and $6.2K (0.4% of Medicare revenue) and ranks at the 49th percentile, while diagnostic fluorescein angiography 92235 accounts for 40 claims and $4.1K (0.3% of Medicare revenue) at the 43th percentile. The relative magnitudes—large revenue shares for branded agents J0178 and J2778 versus a small share for J9035—indicate billed activity dominated by aflibercept and ranibizumab rather than bevacizumab in Medicare claims.

The provider has an established Medicare billing history, with the NPI enumerated 2006-06-07 (~20 years ago), which combined with cumulative Medicare revenue of $1.5M suggests sustained, long‑term engagement in fee‑for‑service Medicare ophthalmology care. This tenure supports interpretation of the observed code mix as a stable operational pattern rather than a transient reporting anomaly.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

10 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,080	$680	$735.5K
J2778	Injection, ranibizumab, 0.1 mg	2,590	$180	$466.2K
J2777	Injection, faricimab‑svoa, 0.1 mg	4,560	$30	$132.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,280	$80	$101K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,750	$30	$50.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	380	$90	$33K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	260	$60	$16K
J9035	Injection, bevacizumab, 10 mg	120	$50	$6.2K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	40	$100	$4.1K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	40	$110	$4K

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 10 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Jeffrey Zheutlin — 1 of 10 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

10 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	30	110	680	$690	$630.2K
J2777	39	60	7,200	$30	$321K
J2778	6	50	730	$180	$240.5K
67028	25	160	440	$90	$57.6K
99214	1,383	15,470	80	$80	$11.4K
J9035	15	30	70	$50	$9.5K
92235	45	100	40	$100	$7.8K
92134	28	820	60	$30	$7.1K
99213	1,604	14,810	60	$60	$6.6K
99204	2,292	6,280	30	$110	$4.2K

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jeffrey Zheutlin, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ebsc, LLC	MI	Ambulatory Surgical Clinic/Center	$1.2M	$953.3K
Kathleen Dehorn	MI	Ophthalmology Physician	$1.7M	$0
Parin Gohel	MI	Ophthalmology Physician	$1.6M	$0
Yosef Gindzin	MI	Ophthalmology Physician	$897.2K	$0
Louis Glazer	MI	Ophthalmology Physician	$896.2K	$0
Christopher Chapman	MI	Ophthalmology Physician	$297.2K	$0
Michael Boyle	MI	Ophthalmic Plastic and Reconstructive Surgery Physician	$53.1K	$0
Leslie Norris	MI	Ophthalmology Physician	$17.9K	$0

Nearby Providers

Other providers in the same ZIP code as Jeffrey Zheutlin, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Reliance Community Care Partners	MI	Case Management Agency	$0	$145.4M
Dental Group Associates PC	MI	Pediatric Dentistry	$0	$16.1M
Pediatric Dental Specialists Of West Michigan	MI	Pediatric Dentistry	$0	$11M
Michigan Pain Consultants PC	MI	Pain Medicine (Anesthesiology) Physician	$0	$9.9M
Mitten Kids Dentistry Cascade Plc	MI	Pediatric Dentistry	$0	$7.2M
Carepoint Dental Anesthesia Group Of Michigan, PLLC	MI	Dental Anesthesiology	$0	$6.4M
Retina Specialists Of Michigan PC	MI	Retina Specialist (Ophthalmology) Physician	$0	$5.5M
Nathan Pezda	MI	Retina Specialist (Ophthalmology) Physician	$1.1M	$0
East Paris Surgical Center, LLC	MI	Ambulatory Surgical Clinic/Center	$968.8K	$30.6K
Liliya Sutherland	MI	Retina Specialist (Ophthalmology) Physician	$880.7K	$0

Jeffrey Zheutlin — Billing Profile & Reimbursement Data

Sign up for Jeffrey Zheutlin — Billing Profile & Reimbursement Data policy alerts

Jeffrey Zheutlin — Billing Profile & Reimbursement Data

Sign up for Jeffrey Zheutlin — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References